Delivery Order SPE2DR25D3010-SPE2DR26F88LS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,773.10 to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 6, 2026, for the supply of Epidiolex 100 mg/ml oral solution in 100 ml packs. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $1,682.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in a 100 ml pack. The contract was competitively awarded without set-aside designation under firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs,...
- The Defense Logistics Agency awarded a delivery order valued at $2,448.04 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 20, 2025. This non-competitive delivery order represents a firm fixed price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution (100 ml pack) with a ceiling value of $8,865.50 under a firm fixed-price contract. The award was made on December 30, 2025, with an ultimate completion date of January 22, 2026. This non-set-aside competitive award represents a single delivery order for the anti-seizure medication, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, with a completion date of October 29, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $3,720.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 milliliters of Epidiolex 100 mg/ml solution on November 5, 2025, with completion targeted for November 28, 2025. This is a non-set-aside delivery order issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be performed at the company's...
- SPE2DR25D3010Indefinite Delivery Contract
- SPE2DR25D3010-SPE2DR26F88LSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,349.88 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 60 ml packs. The contract is non-competitive with a firm fixed-price structure and is scheduled for completion by February 3, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with Cencora, Inc. acting as its parent organization. This delivery order represents a task order issued against a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which authorizes comprehensive pharmaceutical supply services to support military healthcare programs globally. Epidiolex is a FDA-approved cannabidiol medication primarily indicated for seizure disorders, making this procurement consistent with the Defense Health Agency's medical supply requirements for military treatment facilities and healthcare systems. The non-set-aside competitive award reflects AmerisourceBergen's established capability as a major pharmaceutical distributor within the federal procurement ecosystem. This transaction is one of numerous delivery orders the company executes under its prime indefinite delivery vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains required by military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/11/26 |